CAS: 1803171-55-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ravulizumab REF: TM-T76867CAS: 1803171-55-2 | SDS-PAGE:95% SEC-HPLC:95% | 230.00 €~2,490.00 € | Tue 29 Oct 24 |
 | Ravulizumab REF: 3D-CLA1459CAS: 1803171-55-2 | - - - | To inquire | Wed 06 Nov 24 |
Ravulizumab
CAS:1803171-55-2
Ravulizumab (ALXN1210) is a humanized antibody for blocking complement activation, treating PNH, aHUS, and myasthenia …
Purity:
SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Ref: TM-T76867
| 1mg | 230.00 € | ||
| 5mg | 576.00 € | ||
| 10mg | 923.00 € | ||
| 25mg | 1,366.00 € | ||
| 50mg | 1,840.00 € | ||
| 100mg | 2,490.00 € |
Estimated delivery in United States, on Tuesday 29 Oct 2024
Ravulizumab
CAS:1803171-55-2
Anti-Complement component 5 humanized monoclonal antibody; paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome treatment
Ref: 3D-CLA1459
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 6 Nov 2024
